Respiratory

NHS prescribing intelligence on inhalers, spacers, drugs and other devices used in asthma and COPD

The management of respiratory conditions represents a significant percentage of UK community prescribing.With increased NHS focus on the safe and appropriate prescribing of inhaled medicines, GPrX includes a specific respiratory dashboard benchmarking SABA rates at practice level against local and national comparators.

Select from our RxIndexes to see the top-line brand market share movement of some of the most commonly-prescribed inhalers. Full breakdown and trends are available with a GPrX login.